Cemiplimab

AUG 11, 2026 · PHASE 2 TRIAL

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results posted; the study is actively recruiting and outcome data are not yet available.

AUG 7, 2026 · PHASE 2 TRIAL

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial

ClinicalTrials.gov

This is a Phase 2, single-arm registry record with no reported results; it describes an adaptive design testing whether PD-L1–high resectable NSCLC patients can omit chemotherapy, but outcomes are not yet posted.